| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials
|
LeVasseur, Nathalie
|
|
2016
|
50 |
C |
p. 183-193
11 p.
|
artikel
|
| 2 |
Clarification on Tartari et al.: Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients
|
Burke, Thomas
|
|
2016
|
50 |
C |
p. 82-
1 p.
|
artikel
|
| 3 |
Current perspectives of sentinel lymph node dissection at the time of radical surgery for prostate cancer
|
Munbauhal, Gavish
|
|
2016
|
50 |
C |
p. 228-239
12 p.
|
artikel
|
| 4 |
Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation
|
Coutsouvelis, John
|
|
2016
|
50 |
C |
p. 200-204
5 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2016
|
50 |
C |
p. IFC-
1 p.
|
artikel
|
| 6 |
Endocrine treatment in breast cancer: Cure, resistance and beyond
|
Tryfonidis, Konstantinos
|
|
2016
|
50 |
C |
p. 68-81
14 p.
|
artikel
|
| 7 |
Extreme hypofractionation for early prostate cancer: Biology meets technology
|
De Bari, Berardino
|
|
2016
|
50 |
C |
p. 48-60
13 p.
|
artikel
|
| 8 |
Health-related quality of life assessment in contemporary phase III trials in advanced colorectal cancer
|
Adamowicz, Krzysztof
|
|
2016
|
50 |
C |
p. 194-199
6 p.
|
artikel
|
| 9 |
Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications
|
Fazio, Nicola
|
|
2016
|
50 |
C |
p. 61-67
7 p.
|
artikel
|
| 10 |
Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy
|
Calvo, Emiliano
|
|
2016
|
50 |
C |
p. 109-117
9 p.
|
artikel
|
| 11 |
Improving outcomes for older women with gynaecological malignancies
|
Dumas, Lucy
|
|
2016
|
50 |
C |
p. 99-108
10 p.
|
artikel
|
| 12 |
Improving safety of fluoropyrimidine chemotherapy by individualizing treatment based on dihydropyrimidine dehydrogenase activity – Ready for clinical practice?
|
Meulendijks, Didier
|
|
2016
|
50 |
C |
p. 23-34
12 p.
|
artikel
|
| 13 |
Inventory of oral anticancer agents: Pharmaceutical formulation aspects with focus on the solid dispersion technique
|
Sawicki, E.
|
|
2016
|
50 |
C |
p. 247-263
17 p.
|
artikel
|
| 14 |
Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich’s “magic (nano)bullet” for cancer theranostics?
|
Datta, N.R.
|
|
2016
|
50 |
C |
p. 217-227
11 p.
|
artikel
|
| 15 |
Mechanism of drug resistance in relation to site of metastasis: Meta-analyses of randomized controlled trials in advanced breast cancer according to anticancer strategy
|
Niraula, Saroj
|
|
2016
|
50 |
C |
p. 168-174
7 p.
|
artikel
|
| 16 |
Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives
|
Schettini, Francesco
|
|
2016
|
50 |
C |
p. 129-141
13 p.
|
artikel
|
| 17 |
Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge
|
Kandula, Tejaswi
|
|
2016
|
50 |
C |
p. 118-128
11 p.
|
artikel
|
| 18 |
Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens
|
Vogel, Arndt
|
|
2016
|
50 |
C |
p. 142-147
6 p.
|
artikel
|
| 19 |
Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer
|
Criscitiello, Carmen
|
|
2016
|
50 |
C |
p. 205-207
3 p.
|
artikel
|
| 20 |
Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
|
Franceschini, D.
|
|
2016
|
50 |
C |
p. 1-8
8 p.
|
artikel
|
| 21 |
RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
|
Barata, Pedro
|
|
2016
|
50 |
C |
p. 35-47
13 p.
|
artikel
|
| 22 |
Role and therapeutic potential of CDK12 in human cancers
|
Chilà, Rosaria
|
|
2016
|
50 |
C |
p. 83-88
6 p.
|
artikel
|
| 23 |
Selective internal radiation therapy for liver metastases from colorectal cancer
|
Townsend, Amanda R.
|
|
2016
|
50 |
C |
p. 148-154
7 p.
|
artikel
|
| 24 |
Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse
|
Loganadane, Gokoulakrichenane
|
|
2016
|
50 |
C |
p. 240-246
7 p.
|
artikel
|
| 25 |
Systemic treatment and management approaches for medullary thyroid cancer
|
Ernani, Vinicius
|
|
2016
|
50 |
C |
p. 89-98
10 p.
|
artikel
|
| 26 |
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope
|
Morales-Barrera, Rafael
|
|
2016
|
50 |
C |
p. 208-216
9 p.
|
artikel
|
| 27 |
The role of pharmacogenetics in capecitabine efficacy and toxicity
|
Lam, S.W.
|
|
2016
|
50 |
C |
p. 9-22
14 p.
|
artikel
|
| 28 |
To what extent is alcohol consumption associated with breast cancer recurrence and second primary breast cancer?: A systematic review
|
Simapivapan, Phanthira
|
|
2016
|
50 |
C |
p. 155-167
13 p.
|
artikel
|
| 29 |
Trabectedin as a chemotherapy option for patients with BRCA deficiency
|
Monk, Bradley J.
|
|
2016
|
50 |
C |
p. 175-182
8 p.
|
artikel
|
Tijdschrift beschrijving